Gotowa bibliografia na temat „Alzhiemer's disease”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Alzhiemer's disease”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Alzhiemer's disease"
Nevins, A., i S. Cohn. "More Audiovisuals on Alzhiemer's Disease". Gerontologist 25, nr 5 (1.10.1985): 551–52. http://dx.doi.org/10.1093/geront/25.5.551a.
Pełny tekst źródłaNevins, A., i H. Rzetelny. "More Audiovisuals on Alzhiemer's Disease". Gerontologist 25, nr 5 (1.10.1985): 552. http://dx.doi.org/10.1093/geront/25.5.552.
Pełny tekst źródłaFontana, Andrea, i Ronald W. Smith. "Alzheimer's Disease Victims: The “Unbecoming” of Self and the Normalization of Competence". Sociological Perspectives 32, nr 1 (marzec 1989): 35–46. http://dx.doi.org/10.2307/1389006.
Pełny tekst źródłaLiu-Seifert, Hong, Eric Siemers, Karen Price, Baoguang Han, Katherine Selzler, David Henley, Karen Sundell i in. "P2-390: COGNITION IMPAIRMENT PRECEDES AND PREDICTS FUNCTIONAL IMPAIRMENT IN MILD ALZHIEMER's DISEASE". Alzheimer's & Dementia 10 (lipiec 2014): P621. http://dx.doi.org/10.1016/j.jalz.2014.05.1070.
Pełny tekst źródłaRozemuller, J. M., P. Eikelenboom, W. Kamphorst i F. C. Stam. "Lack of evidence for dysfunction of the blood-brain barrier in Alzhiemer's disease: An immunohistochemical study". Neurobiology of Aging 9 (styczeń 1988): 383–91. http://dx.doi.org/10.1016/s0197-4580(88)80085-x.
Pełny tekst źródłaKumari, Rima, Suman Khushwaha i Rohit Gupta. "P1-086: Alzhiemer's disease: Differentiation from other dementias based on quantitative diffusion tensor imaging on 3 Tesla MRI". Alzheimer's & Dementia 5, nr 4S_Part_7 (lipiec 2009): P198. http://dx.doi.org/10.1016/j.jalz.2009.04.090.
Pełny tekst źródłaApostol, Marcin I., Ashley Wright, Matthew Graf, Jon Scherrer, Ken Kosik i James Treanor. "P4-156: DISCOVERY OF NOVEL SMALL MOLECULE THERAPEUTICS FOR ALZHIEMER'S DISEASE BY TARGETING STERIC ZIPPERS INVOLVED IN TAU AGGREGATION". Alzheimer's & Dementia 15 (lipiec 2019): P1334. http://dx.doi.org/10.1016/j.jalz.2019.06.3818.
Pełny tekst źródłaSR, SHARUNYA, VIJAYALAKSHMI DESAI, MEENAKSHI SINGH i KUSUMA M. "Survey on Early Detection of Alzhiemer’s Disease Using Capsule Neural Network". International Journal of Artificial Intelligence 7, nr 1 (23.04.2020): 7–12. http://dx.doi.org/10.36079/lamintang.ijai-0701.65.
Pełny tekst źródłaBezprozvanny, I. "Presenilins function as ER calcium leak channels: Implications for Alzhiemer’s disease". Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 3, nr 3 (wrzesień 2009): 301. http://dx.doi.org/10.1134/s199074780903012x.
Pełny tekst źródłaWojtunik-Kulesza, Karolina A., i Monika Waksmundzka- Hajnos. "Natural terpenes as substances with multidirectional biological activities". Postępy Polskiej Medycyny i Farmacji 6 (8.05.2019): 43–50. http://dx.doi.org/10.5604/01.3001.0013.2320.
Pełny tekst źródłaRozprawy doktorskie na temat "Alzhiemer's disease"
Freer, Rosie. "Molecular origins of tissue vulnerability to aberrant aggregation in protein misfolding diseases". Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/275420.
Pełny tekst źródłaPayne, Magali. "Olfaction, cognition et émotions : liens dans la maladie d'Alzheimer, l'apathie et la COVID-19". Electronic Thesis or Diss., Université Côte d'Azur, 2022. http://www.theses.fr/2022COAZ6013.
Pełny tekst źródłaIn this thesis we created an olfactory test to measure its usefullness to detect disorders such as Alzheimer's disease or apathy syndrome or COVID-19.First, we collected the opinions of clinicians and the recommendations of experts chemists. We then selected fourteen odors, and we developed a computerized olfactory test that was able to calculate threshold and identification automatically using theses odors. We submitted a Patent for this test named "Olfactory Test for screening Alzheimer's disease ans apathy" (TODA).We cerified the interest ol TODA in everyday care practice in the diagnosis of Alzheimer's disease. Using subjects with Alzheimer's disease and healthy control subjects, both in France and Quebec, the test scores significantly differenciate AD subjects from control subjects. This test allowed cognitive monitoring of patients and highlighted odor identification regardless of culture and pathology.With a population of subjects with Minor Cognitive Disorder, with and without apathy, the results were able to significantly differenciate subjects, in particular, with a social sub-dimension of Critéria of Apathy.With subjects suffering from post-COVID-19 infection we tested with the TODA and in parallel we used the Sniffin' Stick Test, a gold standard, to verify the validity of the TODA results. The TODA also allowed us to highlight the problems identify similar odors. Finally, we also highlighted the interest of using the TODA in the case of suspected associated semantics impairment.The comparison of the TODA scores obtained by AD subjects and COVID-19 subjects showed that there was no difference between the two groups. Only the study of the most significant odors made it possible to differenciate between the two patologies
Części książek na temat "Alzhiemer's disease"
Riesner, Detlev. "Protein Aggregation Associated with alzhiemer and Prion Diseases". W Springer Series in Chemical Physics, 225–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-59542-4_11.
Pełny tekst źródłaStreszczenia konferencji na temat "Alzhiemer's disease"
Noel, Rebecca L., Alec J. Batts i Elisa E. Konofagou. "Focused Ultrasound-Induced Blood-Brain Barrier Opening Delays the Onset of Alzhiemer's Disease-Associated Pathology in Male and Female 3xTg Mice". W 2022 IEEE International Ultrasonics Symposium (IUS). IEEE, 2022. http://dx.doi.org/10.1109/ius54386.2022.9957937.
Pełny tekst źródłaShukla, Amar, Rajeev Tiwari i Shamik Tiwari. "Automated Pipeline Preprocessing Techniques for Alzhiemer Disease Detection". W 2022 10th International Conference on Reliability, Infocom Technologies and Optimization (Trends and Future Directions) (ICRITO). IEEE, 2022. http://dx.doi.org/10.1109/icrito56286.2022.9964957.
Pełny tekst źródłaGangyan, Manu, i Pravir Kumar. "VEGF and its role in the treatment of Diabetes and Alzhiemer’s Disease". W 2021 Sixth International Conference on Image Information Processing (ICIIP). IEEE, 2021. http://dx.doi.org/10.1109/iciip53038.2021.9702619.
Pełny tekst źródłaLu, Benjamin M., i Abhinav S. Gurram. "revoAD: Revolutionizing Alzhiemer’s Disease Diagnosis through Multimodal Machine Learning for Universal Screening via Speech and Handwriting Patterns". W 2023 8th International Conference on Intelligent Informatics and Biomedical Sciences (ICIIBMS). IEEE, 2023. http://dx.doi.org/10.1109/iciibms60103.2023.10347810.
Pełny tekst źródła